Regulon

Regulon: R-2018

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
63.35487111Pr-43Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
7132 ENSG00000067182 TNFRSF1A P19438
54498 ENSG00000088826 SMOX Q9NWM0
4897 ENSG00000091129 NRCAM Q92823
5445 ENSG00000105854 PON2 Q15165
2152 ENSG00000117525 F3 P13726
8324 ENSG00000155760 FZD7 O75084

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
GSK-1995057TNFRSF1AAntibodyINHIBITORTumor necrosis factor receptor R1 inhibitor10
TISOTUMAB VEDOTINF3AntibodyBINDING AGENTCoagulation factor III binding agent40
VANTICTUMABFZD5AntibodyANTAGONISTFrizzled-1 antagonist10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2018

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00080LRP2up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-03845DSPup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-04115JAG2up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-06483LGSNup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-14375ST18down-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-15051PTENup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-18007PRPF40Bup-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-24961NLRP1up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-26041PITX2up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-27547CXorf57down-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB

CMF-29790SLC5A7up-regulatesNR3C2activatesR-201821Drugs (3)

Regulator Drugs (0)

Regulon Drugs (3)

GSK-1995057, TISOTUMAB VEDOTIN, VANTICTUMAB